TOKYO -- Cynata Therapeutics will start clinical trials in Japan and the U.S. on a stem-cell-based treatment for transplant patients under a licensing agreement with Fujifilm Holdings, the Australian medical venture's CEO said Friday.
Startups
Australia venture teams with Fujifilm for stem cell therapy
Cynata to run trials in Japan and US for transplant patients
Cynata Therapeutics' stem-cell-based treatment can help leukemia patients fight complications from bone marrow transplants.
Read Next
Latest on Startups
